Prescription Drug Monitoring Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2344: Prescription Drug Monitoring Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2344/
"H.R. 2344: Prescription Drug Monitoring Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2344/.
H.R. 2344, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2344/.
[H.R. 2344: Prescription Drug Monitoring Act of 2021](https://openamerica.io/bill/117-HR-2344/)